Skip to main content
Part of Sickle Cell Disease on Somebody To Talk To

Clinical Trials and Research1 min read

Elevated levels of hormone EPO tied to risk of blood clots in SCD: Large study

About this article

Published
Last updated
Further reading
Read More(opens in a new tab)
Sickle Cell Anemia

Higher blood levels of erythropoietin (EPO), a hormone that stimulates the production of red blood cells, increase the risk of blood clot-related, or thrombotic, events in people with sickle cell disease (SCD), according to a study involving more than 500 patients.

Researchers also discovered a relationship between the production of the EPO receptor (EPOR) protein and blood EPO levels, suggesting that EPOR may be a therapeutic target for preventing abnormal blood clotting in SCD.

Share